BV100: successful end of Phase 2 meeting with US FDA following Positive Phase 2 read-out in Ventilator-Associated Bacterial Pneumonia (VABP); Phase 3 on track to initiate in 2025; Formulation patent ...

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase 2 clinical trial. If approved, the drug, called MariTide, could make Amgen ...

Viking Therapeutics Inc. on Tuesday announced that a trial showed its oral weight-loss drug works — and like a larger rival, its stock price immediately suffered. Viking’s stock dived 40% in early ...

FDA fast tracks GLSI-100 for HER2-positive breast cancer, promising new hope for patients with unmet medical needs. Discover ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

Baxdrostat showed a significant reduction in systolic blood pressure at 12 weeks vs. placebo. Trial met all primary and secondary endpoints; drug was well tolerated. Up Next: Wall Street trader’s 34-0 ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. CHICAGO — Amgen’s monthly ...

Sept 2 (Reuters) - Merck's (MRK.N), opens new tab oral drug met the main goal of reducing bad cholesterol in a late-stage trial, it said on Tuesday, marking a second win for the drug since June. The ...

Eli Lilly's approved blood cancer therapy Jaypirca helped delay progression of the disease in previously untreated patients ...

Trial will evaluate DF-003, a first-in-class ALPK1 inhibitor that specifically targets the genetic root cause of ROSAH syndrome Drug Farm, a private biotechnology company utilizing genetics and ...